Hormonal
Baseline body mass index (BMI), glycated haemoglobin (HbA1c), and triglyceride levels can accurately predict future glycaemic control trajectories (stable, improved, or deteriorated) in patients with newly diagnosed type 2 diabetes.
If you have been newly diagnosed with type 2 diabetes, your doctor can use three simple numbers from your initial blood work—your BMI, your HbA1c, and your triglycerides—to predict how your blood sugar will likely behave over the next few years. This helps them decide whether you need frequent check-ups or if standard care is sufficient, allowing for more personalized management of your condition.
Body mass index and glycated haemoglobin and triglyceride levels were the most important predictors of trajectory membership. The predictive model, trained on the development cohort, had a receiver-operating characteristic area under the curve of 0.96 in the validation cohort, indicating excellent accuracy.
Why this rating
Retrospective cohort study with large sample sizes (n=10,528 development, n=3,337 validation) and external validation, though observational nature limits causal inference.
Source
A risk score including body mass index, glycated haemoglobin and triglycerides predicts future glycaemic control in people with type 2 diabetes
Dorijn F. L. Hertroijs et al. · Diabetes Obesity and Metabolism · 2017
DOI 10.1111/dom.13148
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →